Literature DB >> 26737837

Statically vs dynamically balanced gait: Analysis of a robotic exoskeleton compared with a human.

Giulia Barbareschi, Rosie Richards, Matt Thornton, Tom Carlson, Catherine Holloway.   

Abstract

In recent years exoskeletons able to replicate human gait have begun to attract growing popularity for both assistive and rehabilitative purposes. Although wearable robots often need the use of external support in order to maintain stability, the REX exoskeleton by REX Bionics is able to self-balance through the whole cycle. However this statically balanced gait presents important differences with the dynamically balanced gait of human subjects. This paper will examine kinematic and kinetic differences between the gait analysis performed on a subject wearing the REX exoskeleton and human gait analysis data as presented in literature. We will also provide an insight on the impact that these differences can have for both rehabilitative and assistive applications.

Entities:  

Mesh:

Year:  2015        PMID: 26737837     DOI: 10.1109/EMBC.2015.7319937

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  10 in total

1.  Muscular activity and physical interaction forces during lower limb exoskeleton use.

Authors:  Matthew Wilcox; Ashish Rathore; Dafne Zuleima Morgado Ramirez; Rui C V Loureiro; Tom Carlson
Journal:  Healthc Technol Lett       Date:  2016-12-14

2.  Gait-Assist Wearable Robot Using Interactive Rhythmic Stimulation to the Upper Limbs.

Authors:  Robin Miao Sin Yap; Ken-Ichiro Ogawa; Yuki Hirobe; Terumasa Nagashima; Masatoshi Seki; Masayuki Nakayama; Ken Ichiryu; Yoshihiro Miyake
Journal:  Front Robot AI       Date:  2019-04-24

3.  Robust adaptive PD-like control of lower limb rehabilitation robot based on human movement data.

Authors:  Ningning Hu; Aihui Wang; Yuanhang Wu
Journal:  PeerJ Comput Sci       Date:  2021-02-24

4.  Effects of therapy with a free-standing robotic exoskeleton on motor function and other health indicators in people with severe mobility impairment due to chronic stroke: A quasi-controlled study.

Authors:  Nicola Postol; Jessica Grissell; Caitlyn McHugh; Andrew Bivard; Neil J Spratt; Jodie Marquez
Journal:  J Rehabil Assist Technol Eng       Date:  2021-10-23

5.  A Multi-Modal Gait Database of Natural Everyday-Walk in an Urban Environment.

Authors:  Viktor Losing; Martina Hasenjäger
Journal:  Sci Data       Date:  2022-08-03       Impact factor: 8.501

6.  Team IHMC at the 2020 Cybathlon: a user-centered approach towards personal mobility exoskeletons.

Authors:  Brandon Peterson; Mark Daniel; Vishnu Subra Mani; Brooke Arnold; Travis Craig; Jeremy Gines; Carlos Gonzalez; William Howell; Brandon Shrewsbury; Matthew Bellman; Peter Neuhaus; Robert Griffin
Journal:  J Neuroeng Rehabil       Date:  2022-09-27       Impact factor: 5.208

7.  Evaluation of safety and performance of the self balancing walking system Atalante in patients with complete motor spinal cord injury.

Authors:  Jacques Kerdraon; Jean Gabriel Previnaire; Maegan Tucker; Pauline Coignard; Willy Allegre; Emmanuel Knappen; Aaron Ames
Journal:  Spinal Cord Ser Cases       Date:  2021-08-04

8.  Stability of Mina v2 for Robot-Assisted Balance and Locomotion.

Authors:  Carlotta Mummolo; William Z Peng; Shlok Agarwal; Robert Griffin; Peter D Neuhaus; Joo H Kim
Journal:  Front Neurorobot       Date:  2018-10-15       Impact factor: 2.650

9.  Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity.

Authors:  Atif S Khan; Donna C Livingstone; Caitlin L Hurd; Jennifer Duchcherer; John E Misiaszek; Monica A Gorassini; Patricia J Manns; Jaynie F Yang
Journal:  J Neuroeng Rehabil       Date:  2019-11-21       Impact factor: 4.262

10.  Physiotherapy using a free-standing robotic exoskeleton for patients with spinal cord injury: a feasibility study.

Authors:  Nicola Postol; Neil J Spratt; Andrew Bivard; Jodie Marquez
Journal:  J Neuroeng Rehabil       Date:  2021-12-25       Impact factor: 4.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.